uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 13, 2017

Hi-Tech To Pay Over 40 Million to Settle FTC Charges of False Claims

On October 11, 2017, a U.S. District Judge ruled that Hi-Tech Pharmaceuticals Inc. violated permanent legal injunctions disallowing supplement distributors to make unsubstantiated claims about Hi-Tech's weight-loss products, Fastin, Stimerex-ES, Benzedrine, and a reformulated version of Lipodrene. The company printed unfounded advertisements about four of their products, and three individuals, including the CEO Jared Wheat, were found responsible.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at